Hypermarcas (OTCMKTS:HYPMY) Sees Large Volume Increase – Time to Buy?

Hypermarcas (OTCMKTS:HYPMY) shares saw strong trading volume on Friday . 28,871 shares changed hands during trading, an increase of 25% from the previous session’s volume of 23,057 shares.The stock last traded at $4.61 and had previously closed at $4.63.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Hypermarcas presently has a consensus rating of “Buy”.

Hypermarcas Trading Down 0.3%

The firm has a market capitalization of $3.25 billion, a price-to-earnings ratio of 9.62 and a beta of 0.73. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27. The company has a 50-day moving average price of $4.46 and a 200-day moving average price of $4.52.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. As a group, research analysts forecast that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.